Formulation Strategies For Solubility Enhancement Of Fusidic Acid Using Solid Dispersion Techniques

Authors

  • Abhijeet B Survase
  • Samrat A Khedkar
  • Somnath H Nagane

Keywords:

Fusidic acid, Solid dispersion, Carrier, Dissolution

Abstract

Fusidic acid is a poorly water-soluble antibiotic that exhibits limited oral bioavailability due to its low dissolution rate. The present study aimed to enhance the solubility of fusidic acid using the solid dispersion technique. Solid dispersions were prepared by the solvent evaporation method employing hydrophilic carriers, namely polyvinylpyrrolidone (PVP K30) and polyethylene glycol (PEG 4000), at different drug-to-polymer ratios. The prepared formulations were evaluated for percentage yield, drug content, and physicochemical characteristics using Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) analysis. The results demonstrated a significant improvement in the solubility and dispersion of fusidic acid in the presence of hydrophilic carriers. Among the formulations, those containing PVP K30 showed superior performance in enhancing drug release compared to PEG 4000, indicating its effectiveness as a carrier. FTIR studies confirmed the absence of significant drug–excipient interactions, while XRD analysis revealed a reduction in crystallinity, suggesting partial conversion of the drug into an amorphous form. The solid dispersion technique using PVP K30 is a promising approach for improving the solubility of fusidic acid. Further studies are recommended to evaluate long-term stability and in vivo performance.

Downloads

Download data is not yet available.

References

[1] Saffoon, N., Uddin, R., Huda, N.H. and Sutradhar, K.S. (2011) ‘Enhancement of oral bioavailability and solid dispersion: A review’, Journal of Applied Pharmaceutical Science, 1(7), pp. 13–20.

[2] Drug Bank (2024) Fusidic acid. Available at: https://go.drugbank.com/drugs/DB02703

[3] National Health Service (2023) Fusidic acid: About fusidic acid. Available at: https://www.nhs.uk/medicines/fusidic-acid/

[4] Science Direct (2024) Fusidic acid overview. Available at: https://www.sciencedirect.com

[5] Wikipedia (2024) Fusidic acid. Available at: https://en.wikipedia.org/wiki/Fusidic_acid

[6] Brown, D.F.J., Edwards, D.I., Hawkey, P.M. et al. (2005) ‘Laboratory diagnosis and susceptibility testing of MRSA’, Journal of Antimicrobial Chemotherapy, 56, pp. 1000–1018.

[7] Tekade, A.R. and Yadav, J.N. (2020) ‘A review on solid dispersion and carriers used therein for solubility enhancement of poorly water-soluble drugs’, Advanced Pharmaceutical Bulletin, 10(3), pp. 359–.

[8] Huang, B.B., Liu, D.X., Liu, D.K. and Wu, G. (2019) ‘Application of solid dispersion technique to improve solubility and sustain release of emamectin benzoate’, Molecules, 24(23), p. 4315.

[9] Dabhade, D., Wadher, K., Bute, S., Naidu, N., Umekar, M. and Anantwar, S. (2021) ‘Preparation and characterization of artemether solid dispersion by spray drying technique’, Journal of Drug Delivery, 11(2), pp. 1–5.

[10] Leuner, C. and Dressman, J. (2000) ‘Improving drug solubility for oral delivery using solid dispersions’, European Journal of Pharmaceutics and Biopharmaceutics, 50, pp. 47–60.

[11] Lipinski, C.A. (2000) ‘Drug-like properties and solubility issues’, Journal of Pharmacological and Toxicological Methods, 44, pp. 235–249.

[12] Vasconcelos, T., Sarmento, B. and Costa, P. (2007) ‘Solid dispersions as a strategy to improve bioavailability’, Drug Discovery Today, 12, pp. 1068–1075.

[13] Liw, J.J., Teoh, X.Y., Teoh, A.X. and Chan, S.Y. (2022) ‘The effect of carrier-drug ratios on dissolution performances of poorly soluble drug in crystalline solid dispersion system’, Journal of Pharmaceutical Sciences, 111(1), pp. 95–101.

[14] Patel, P., Mahajan, A. and Thakor, N. (2020) ‘Enhancement of solubility and dissolution of clopidogrel bisulfate by solid dispersion in combination with surface adsorbent’, Pharmacophore, 11(5).

[15] Iqbal, A., Hossain, S., Shamim, A., Islam, M. and Siddique, A.T. (2020) ‘Formulation, in vitro evaluation and characterization of atorvastatin solid dispersion’, Tropical Journal of Pharmaceutical Research, 19(6), pp. 1131–1138.

Singh, J., Walia, M. and Harikumar, S.L. (2013) ‘Solubility enhancement by solid dispersion method: A review’, Journal of Drug Delivery and Therapeutics, 3(5), pp. 148–155.

Downloads

Published

2025-12-12

How to Cite

1.
B Survase A, A Khedkar S, H Nagane S. Formulation Strategies For Solubility Enhancement Of Fusidic Acid Using Solid Dispersion Techniques. J Neonatal Surg [Internet]. 2025 Dec. 12 [cited 2026 Jul. 26];14(33S):1216-24. Available from: https://jneonatalsurg.com/index.php/jns/article/view/10398

Issue

Vol. 14 No. 33S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.